-
Results from an exploratory biomarker analysis evaluating MET expression as a predictor of clinical response to rilotumumab (AMG 102) conducted on a previously reported Phase II study of rilotumumab i n...
» Read more
-
A subpopulation analysis of data from two phase III studies shows that
fidaxomicin (Dificid®,
Optimer Pharmaceuticals, Inc.)tablets offered faster diarrheal symptom improvement than or al...
» Read more
-
Updated results from a Phase II study that showed treatment with blinatumomab (AMG 103/MT103,
Amgen, Inc/Micromet AG,) helped achieve a high-rate of complete response (CR) in 72% of adult patien ts...
» Read more
-
The first head-to-head comparison of high throughput sequencing (HTS) using immunoSEQ™ (Adaptive Biotechnologies and traditional flow cytometry conducted in collaboration with Fred Hutchinson Ca ncer...
» Read more
-
The first cohort in a U.S. multi-center Phase 1b dose-escalation trial of a novel cancer-targeted molecular radiotherapeutic compound (I-131-CLR1404; Novelos Therapeutics, Inc.), in cancer patients wi th...
» Read more
-
The UK National Institute for Health and Clinical Excellence (NICE), an independent organisation responsible for providing national (UK) guidance and standards on the promotion of good health and the prevention...
» Read more
-
Earlier today, the today European Commission confirmed that it has approved a conditional marketing authorization pixantrone (Pixuvri®, Cell Therapeutics), also known as BBR 2778, as monother apy...
» Read more
-
In response to today's Perspective pieces published in the New England Journal Of Medicine (NEJM), the National Bone Health Alliance (NBHA), a public-private partnership bringing together the expertis e...
» Read more
-
Young adults are increasing their risk for developing skin cancer, according to two studies by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI). One study, of...
» Read more
-
Health care reform, specifically the Health Information Technology for Economic and Clinical Health (HITECH) Act, is transforming the way patients and doctors will interact as our healthcare system di gitizes...
» Read more